Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: Positive correlation with disease severity

Motozumi Minohara, Takeshi Matsuoka, Wei Li, Manabu Osoegawa, Takaaki Ishizu, Yasumasa Ohyagi, Jun ichi Kira

Research output: Contribution to journalArticlepeer-review

45 Citations (Scopus)

Abstract

To clarify the role of myeloperoxidase (MPO) in multiple sclerosis (MS), we measured serum MPO levels in 86 Japanese patients with relapsing remitting MS, 47 with opticospinal MS (OSMS) and 39 with conventional MS (CMS), and 85 healthy subjects by sandwich enzyme immunoassays and analyzed relationships with clinical features. We found a significant increase in serum MPO in OSMS patients at relapse and remission, and in CMS patients at remission compared with controls. By logistic regression analysis, the clinical variable associated with high level of MPO at remission in OSMS patients (higher than the mean ± 2 S.D. of healthy controls) was only Kurtzke's Expanded Disability Status Scale (EDSS) score in blood sampling (p = 0.0245); that is, a greater EDSS scores in the high MPO group, whereas in CMS none were associated. The results of our study suggest that MPO levels in remission are related with severe tissue destruction in OSMS.

Original languageEnglish
Pages (from-to)156-160
Number of pages5
JournalJournal of Neuroimmunology
Volume178
Issue number1-2
DOIs
Publication statusPublished - Sep 1 2006

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: Positive correlation with disease severity'. Together they form a unique fingerprint.

Cite this